Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
2024 election results: Presidential election, Congressional balance of power, your local results
Recommended
Vote now: 2024 WRAL Voters' Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aurinia Pharm Ord
(NQ:
AUPH
)
8.340
+0.820 (+10.90%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharm Ord
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Aurinia Pharmaceuticals: Q3 Earnings Insights
November 03, 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...
Via
Benzinga
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
November 03, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis
November 01, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
No Negative Reaction
October 28, 2021
Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.
Via
Talk Markets
Analyzing Aurinia Pharmaceuticals's Unusual Options Activity
August 11, 2021
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021
October 28, 2021
Upgrades For Boot Barn Holdings Inc (NYSE:
Via
Benzinga
Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021
October 27, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021
October 26, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Cyber Currency
October 26, 2021
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.
Via
Talk Markets
Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass?
October 25, 2021
Aurinia stock hit another record Monday on Bristol's rumored takeover.
Via
Investor's Business Daily
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
October 22, 2021
The biotech is reportedly in buyout talks with Bristol Myers Squibb.
Via
The Motley Fool
Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover
October 22, 2021
Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.
Via
Investor's Business Daily
55 Biggest Movers From Friday
October 25, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...
Via
Benzinga
More Chinese Trouble
October 14, 2021
A day after the consumer price rise there was another price rise for producer markets.
Via
Talk Markets
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...
Via
Benzinga
Pharma, Tech and Finance
September 20, 2021
Good news on some drugs was not enough to boost stock markets.
Via
Talk Markets
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
September 15, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Sunday Special
September 12, 2021
I have a taste for nuclear electricity which France pioneered decades ago, building power stations along the Loire Valley and in other regions. So I took my taste for uranium into my US holdings.
Via
Talk Markets
Topics
Energy
Exposures
Electricity Generation
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
Post-Rosh Hashanah, Sell?
September 08, 2021
As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year?
Via
Talk Markets
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
Aurinia Pharmaceuticals finalizes acquisition agreement with Leading Pharma Giant
August 26, 2021
Via
Get News
Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock
August 17, 2021
Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average.
Via
Investor's Business Daily
Aurinia Adds Two Assets To Expand Its Immunology Pipeline
August 17, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was...
Via
Benzinga
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases
August 17, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference
August 09, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet
August 06, 2021
Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
84 Biggest Movers From Friday
August 09, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.